Biomerica Inc (BMRA) - Total Liabilities
Based on the latest financial reports, Biomerica Inc (BMRA) has total liabilities worth $1.56 Million USD as of February 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Biomerica Inc to see how much of total assets are deployed in long-term investments.
Biomerica Inc - Total Liabilities Trend (1986–2025)
This chart illustrates how Biomerica Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BMRA total asset value.
Biomerica Inc Competitors by Total Liabilities
The table below lists competitors of Biomerica Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GREENHY2 Ltd
AU:H2G
|
Australia | AU$1.25 Million |
|
Tourn International AB
ST:TOURN
|
Sweden | Skr20.46 Million |
|
INDUSTRIAL MINERALS LTD
F:9ED
|
Germany | €490.04K |
|
Polar Capital Global Financials Trust plc
LSE:PCFT
|
UK | GBX50.05 Million |
|
Bio Green Med Solution, Inc.
NASDAQ:BGMS
|
USA | $1.34 Million |
|
PVW Resources Ltd
AU:PVW
|
Australia | AU$1.02 Million |
|
Fidelity Asian Values
LSE:FAS
|
UK | GBX6.54 Million |
|
Purple Biotech Ltd
TA:PPBT
|
Israel | ILA6.25 Million |
Liability Composition Analysis (1986–2025)
This chart breaks down Biomerica Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Biomerica Inc (BMRA) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biomerica Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biomerica Inc (1986–2025)
The table below shows the annual total liabilities of Biomerica Inc from 1986 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-05-31 | $1.84 Million | -30.90% |
| 2024-05-31 | $2.66 Million | -2.45% |
| 2023-05-31 | $2.73 Million | -10.48% |
| 2022-05-31 | $3.05 Million | +17.66% |
| 2021-05-31 | $2.59 Million | -14.93% |
| 2020-05-31 | $3.05 Million | +140.97% |
| 2019-05-31 | $1.26 Million | +40.99% |
| 2018-05-31 | $896.81K | +69.57% |
| 2017-05-31 | $528.87K | +4.51% |
| 2016-05-31 | $506.03K | -3.42% |
| 2015-05-31 | $523.93K | -5.74% |
| 2014-05-31 | $555.84K | -0.72% |
| 2013-05-31 | $559.89K | -5.47% |
| 2012-05-31 | $592.29K | -5.24% |
| 2011-05-31 | $625.01K | -34.37% |
| 2010-05-31 | $952.30K | +18.43% |
| 2009-05-31 | $804.09K | -34.29% |
| 2008-05-31 | $1.22 Million | -16.86% |
| 2007-05-31 | $1.47 Million | +7.87% |
| 2006-05-31 | $1.36 Million | -39.56% |
| 2005-05-31 | $2.26 Million | +9.90% |
| 2004-05-31 | $2.05 Million | -10.76% |
| 2003-05-31 | $2.30 Million | +16.21% |
| 2002-05-31 | $1.98 Million | +8.41% |
| 2001-05-31 | $1.83 Million | -0.01% |
| 2000-05-31 | $1.83 Million | +14.22% |
| 1999-05-31 | $1.60 Million | +23.08% |
| 1998-05-31 | $1.30 Million | -13.33% |
| 1997-05-31 | $1.50 Million | -25.00% |
| 1996-05-31 | $2.00 Million | -23.08% |
| 1995-05-31 | $2.60 Million | -13.33% |
| 1994-05-31 | $3.00 Million | -14.29% |
| 1993-05-31 | $3.50 Million | -14.63% |
| 1992-05-31 | $4.10 Million | -14.58% |
| 1991-05-31 | $4.80 Million | +9.09% |
| 1990-05-31 | $4.40 Million | +780.00% |
| 1989-05-31 | $500.00K | -28.57% |
| 1988-05-31 | $700.00K | -58.82% |
| 1987-05-31 | $1.70 Million | +21.43% |
| 1986-05-31 | $1.40 Million | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and oth… Read more